Clinical Trials Logo

Elevated Blood Pressure clinical trials

View clinical trials related to Elevated Blood Pressure.

Filter by:

NCT ID: NCT05297708 Recruiting - Clinical trials for Elevated Blood Pressure

Office, Home, and Ambulatory Blood Pressure

HBPA
Start date: March 24, 2022
Phase:
Study type: Observational

This will be a prospective observational study. The population would be pediatric patients 6 years to <19 years of age who were referred for elevated blood pressure to investigate if home blood pressure (HBP) can determine blood pressure phenotype (normotensive, hypertensive, masked hypertension, white coat hypertension) as accurately as ambulatory blood pressure monitor (ABPM) in childhood and adolescence.

NCT ID: NCT05121337 Recruiting - Hypertension Clinical Trials

Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension

GoFresh
Start date: September 30, 2022
Phase: N/A
Study type: Interventional

GoFresh is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults, residing in Boston area urban food deserts.

NCT ID: NCT05062161 Active, not recruiting - Hypertension Clinical Trials

Sleep Duration and Blood Pressure During Sleep

Start date: September 30, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the impact that sleep duration has on blood pressure (BP) levels during sleep. The investigator will examine the effect of an 8-week sleep hygiene/extension intervention vs. control on sleep BP.

NCT ID: NCT05029427 Completed - Clinical trials for Elevated Blood Pressure

Effect of Oat Beta Glucan in Managing Blood Pressure

Start date: November 28, 2021
Phase: N/A
Study type: Interventional

This is a randomized, double-blinded, cross-over pilot study comparing the effects of ingesting oats containing high molecular weight β-glucan in reducing blood pressure.

NCT ID: NCT04953650 Completed - Clinical trials for Intermittent Fasting

Intermittent Fasting Towards Elevated Blood Pressure

Start date: September 27, 2021
Phase: N/A
Study type: Interventional

To date, the prevalence of Hypertension (HPT) is getting increase worldwide. This situation is contributed mostly by the Lower-Income Countries (LIC) and Lower-Middle-Income Countries (LMICs) include Asians. Elevated Blood Pressure (EBP) in the early phase is often unrealized before developing to HPT, leading to several diseases in terms of cardiovascular diseases (CVDs). In preventing EBP, the European Society of Cardiology in 2017 classifies blood pressure into three groups; normal, pre-hypertension, and hypertensive crisis. People in the normal phase with the high-normal line are classified into EBP. If this group is determined and controlled, they will further keep in normal blood pressure. Contrarily, they are experiencing the next phase of HPT. Like other Asian countries, Indonesia was experiencing an extreme prevalence of HPT, and Aceh, which is one of the provinces in Indonesia has a very high prevalence of HPT as well (20% increment from 2013-2018), is estimated to equal to the EBP prevalence. Despite many promotive and preventive interventions confirmed to decrease HPT, early screening has been convinced to recover the HPT in Indonesia. However, the HPT prevalence was examined steadily increasing. Intermittent fasting (IF) is recognized as a new method in decreasing metabolic factors based on several types of research currently. Therefore, the investigators are studying the effectiveness of intermittent fasting on people with EBP. Conducting healthy lifestyle intervention that is inexpensive, doable, and easily accessible, would be a new method for controlling EBP.

NCT ID: NCT04766424 Active, not recruiting - Clinical trials for Elevated Blood Pressure

Sleep Technology Intervention to Target Cardiometabolic Health

STITCH
Start date: March 30, 2021
Phase: N/A
Study type: Interventional

The goal of this study is to test the efficacy of a behavioral sleep extension intervention on sleep duration, cardio-metabolic disease risk factors, and health behaviors among adults with elevated blood pressure/hypertension and short sleep duration.

NCT ID: NCT04402385 Terminated - Pre-Eclampsia Clinical Trials

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

Start date: August 6, 2020
Phase: Phase 2
Study type: Interventional

To determine if low dose aspirin reduces the incidence of hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome) in pregnant women with stage 1 hypertension and elevated blood pressure.

NCT ID: NCT04298944 Completed - Hypertension Clinical Trials

Association of Mood With Risk for Atherosclerosis

AuRA
Start date: March 11, 2020
Phase:
Study type: Observational [Patient Registry]

The investigators will aim to determine the association of mood disorders (MDO) with preclinical and clinical cardiovascular (CVD) risk factors among children. The investigators will also aim to identify traditional and non traditional predictors of CVD risk among children with MDO.

NCT ID: NCT04003597 Completed - Clinical trials for Elevated Blood Pressure

'Low-salt' Bread as a Means of Reducing Dietary Salt and Lowering Blood Pressure

Saltbreads
Start date: January 3, 2008
Phase: N/A
Study type: Interventional

In the context of public health, reformulation of bread in terms of salt content remains an important measure to help achieve a reduction in salt intake in the population. Therefore, the aim of this study was to examine, using a 5-week cross-over design, food-based intervention trial, the potential for inclusion of 'low-salt' bread as part of a pragmatic reduced-salt diet on blood pressure (BP) in adults with slightly to moderately elevated BP. The study consisted of a randomized crossover trial of the effect of reduced-salt intake or usual-salt intake for 5 weeks on BP (as the primary outcome) in adults with slightly to moderately elevated BP (seated office systolic BP >120 and <160 mmHg or a diastolic BP >80 and <95 mmHg; identified by a pre-screening phase). Subjects were randomly assigned to the reduced-salt diet or their usual-salt diet (control) for 5 weeks, followed by crossover to the alternative dietary regimen for a further 5 weeks. Subjects randomized to start on the reduced-salt diet were asked to restrict their consumption of dietary salt using a combination of pragmatic dietary advice as well as the replacement of bread and a limited number of other foods with equivalent foods which had lower salt content; these were provided to the participants. At the beginning of the salt restriction period, a research nutritionist provided the subjects with a list of the common salt-containing food and were asked to limit the consumption of such, as feasible. The subjects received in-house prepared 'low-salt (<0.3 g/100 g)' brown or white sliced pan bread as well as no-salt margarine/butter, and were given luncheon meats with no added salt, if desired (optional); these were supplied regularly by the research staff. Subjects commencing the trial on the control diet were allowed to follow their usual diet but were asked to consume an in-house produced brown or white sliced pan bread equivalent in composition to the low-salt version but with its more typical salt content (1.2 g/100 g). Participants met the research staff weekly to receive breads and no-salt margarine/butter as well as luncheon meats (where applicable), and at these meetings the staff promoted compliance with the intervention and encouraged completion of the study protocol. BP and other assessments were made at baseline and at the end of week 5 and week 10.

NCT ID: NCT03993184 Completed - Hypertension Clinical Trials

The Effects of Hot Yoga on Vascular Function

Start date: April 17, 2018
Phase: N/A
Study type: Interventional

This study will examine the effects of a 12 week hot yoga intervention on vascular health in adults between the ages of 20 and 65. The investigators are seeking individuals with slightly elevated blood pressure and stage I hypertension who are not currently taking blood pressure medications or exercising regularly. Participants will receive 12 weeks of free yoga for their participation.